# Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Study · id `cardio:ct-nct01128816` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01128816](<https://clinicaltrials.gov/study/NCT01128816>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01128816

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 732 participants.

## Technical summary

Registry record NCT01128816. Randomized; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2022-03-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 732 participants (enrolled count; ClinicalTrials.gov record NCT01128816, source copy `cardio:ctgov-nct01128816-2022-11-22`, retrieved 2026-10-26)
- Start date: 2010-05 (registry gives no type) (ClinicalTrials.gov record NCT01128816, source copy `cardio:ctgov-nct01128816-2022-11-22`, retrieved 2026-10-26)
- Primary completion: 2022-03-31 (actual) (ClinicalTrials.gov record NCT01128816, source copy `cardio:ctgov-nct01128816-2022-11-22`, retrieved 2026-10-26)
- Completion: 2022-03-31 (actual) (ClinicalTrials.gov record NCT01128816, source copy `cardio:ctgov-nct01128816-2022-11-22`, retrieved 2026-10-26)
- Countries: United States; Brazil; Canada; France; Germany; Italy; Japan; Spain; United Kingdom (ClinicalTrials.gov record NCT01128816, source copy `cardio:ctgov-nct01128816-2022-11-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01128816-2022-11-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure
- Acronym: ADVENT-HF
- Condition: Sleep Apnea
- Condition: Heart Failure
- Intervention (Device): Adaptive Servo Ventilation
- Lead sponsor: Toronto Rehabilitation Institute
- Lead sponsor class: OTHER
- Collaborator: Canadian Institutes of Health Research (CIHR)
- Collaborator class: OTHER\_GOV
- Collaborator: Philips Respironics
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Canadian Institutes of Health Research (CIHR) (`cardio:org-canadian-institutes-of-health-research-cihr`)
- Registry lists this organization as a collaborator: Philips Respironics (`cardio:org-philips-respironics`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial (`cardio:pubmed-38142697`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Nocturnal Cardiac Arrhythmias in Heart Failure With Obstructive and Central Sleep Apnea (`cardio:pubmed-39168180`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Win Ratio Analysis for Peak-Flow Adaptive Servoventilation in Treating Sleep Apnoea in Heart Failure With Reduced Ejection Fraction (`cardio:pubmed-41865991`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e20fbe09d5d3f34550b1ebd093d368e597969e64c817e90f3cfafa3b75793ede
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
